A Year in Review: 2025
By
Substantial Research Progress and Fundraising Success
Pilot Recellularization Results
Confirming scaffold viability and cell growth
December Matching Campaign Success!
We crushed our goal! Thank you for raising nearly $60k with the match.
Scaling Up Recellularization, Unprecedented Biomechanics Data, and In Vivo Safety Testing
Larger samples, rigorous testing, and long-term safety data from our labs in Slovakia and Austria.
February 1st, 2026
From pilot success to full-scale protocols—plus, join Jan Kovac and William Musa for an exclusive bioreactor tour.
January 4th, 2026
$62,959 Raised: A Fundraising Win for the New Year!
There and Back Again: Biomaterials, Biocompatibility, and Foregen’s Research (Part 3)
Animal Model
April 12th, 2022
Newsletter
There and Back Again: Biomaterials, Biocompatibility, and Foregen’s Research (Part 2)
March 12th, 2022
There and Back Again: Biomaterials, Biocompatibility, and Foregen’s Research (Part 1)
February 10th, 2022
Rat Model Overview
Animal Trials
A Year in Review: 2021
Looking Back
January 11th, 2022
Commentarium
by foregen